Celgene

Visual Financials
Company Name: Celgene Corp
Ticker Symbol: CELG
CIK Number: 0000816284
WWW Address: http://www.celgene.com
CEO: Mark J. Alles
No. of Employees: 7,132
Common Issue Type: CS
Business Description:Celgene Corporation is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 98.085 Up 0.255 98.08 98.09 98.0 95.80 95.06 1809828
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 69,175.4 705.3 0.00 5.65 0.00 16.9 0.0 98.00 - 58.59
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close95.19$
PE Ratio - LTM16.9
Market Capitalisation69,175.4mil
Latest Shares Outstanding705.3mil
Earnings pS (EPS)5.65$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee1,726,277$
Effective Tax Rate0.2%
Float701.3mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.20%
Research & Devlopment (R&D) as % of Revenue0.40%
Gross Profit Margin96.2%
EBITDA Margin40.6%
Pre-Tax Profit Margin0.0%
Assets Turnover46.6%
Return on Assets (ROA)12.3%
Return on Equity (ROE)61.9%
Return on Capital Invested (ROCI)18.6%
Current Ratio2.2
Leverage Ratio (Assets/Equity)5.8
Interest Cover7.5
Total Debt/Equity (Gearing Ratio)3.29
LT Debt/Total Capital76.0%
Working Capital pS7.10$
Cash pS0.00$
Book-Value pS11.58$
Tangible Book-Value pS-25.60$
Cash Flow pS9.66$
Free Cash Flow pS9.23$
KEY FIGURES (LTM): Price info
Price/Book Ratio8.22
Price/Tangible Book Ratio0.00
Price/Cash Flow9.9
Price/Free Cash Flow10.3
P/E as % of Industry Group137.0%
P/E as % of Sector Segment27.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---1.54,325,57416,839,914
4 Weeks96.4893.2695.51-0.34,361,26482,864,025
13 Weeks97.0784.1884.4612.77,211,160454,303,142
26 Weeks98.0058.5970.0835.88,992,5271,115,073,424
52 Weeks98.0058.5979.0620.47,235,8601,808,965,239
YTD98.0062.67-42.89,325,9871,007,206,683
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
94.8894.8094.7485.2485.200.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.190.40.18
Income0.230.60.36
Dividend0.0
Capital Spending0.18NA0.28
R&D27.48NA26.34
Normalized Inc.47.92NA26.04
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %15.015.013.7
Earnings %-4.1-4.110.5
EPS %-1.1-1.115.8
EPS $-0.01-0.010.45
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio14.12
Current Ratio2.2
Quick Ratio (Acid Test)2.0
Liquidity Ratio (Cash)2.53
Receivables Turnover7.7
Average Collection Period47
Working Capital/Equity81.3
Working Capital pS7.14
Cash-Flow pS7.05
Free Cash-Flow pS6.60
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio1.25
Financial Leverage Ratio (Assets/Equity)3.3
Debt Ratio57.1
Total Debt/Equity (Gearing Ratio)3.29
LT Debt/Equity3.21
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities97.5
Interest Cover7.5
Interest/Capital Invested12.03
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.89
Current P/E Ratio - LTM16.90
Enterprise Value (EV)/EBITDA9.16
Enterprise Value (EV)/Free Cash Flow14.91
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM8.22
Price/Cash Flow Ratio9.9
Price/Free Cash Flow Ratio - LTM10.3
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM39.4
P/E Ratio (26 weeks ago) - LTM22.0
P/E Ratio (52 weeks ago) - LTM20.6
5-Y High P/E Ratio22.5
5-Y Low P/E Ratio8.9
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E-7
P/E as % of Industry Group137.0
P/E as % of Sector Segment27.0
Current 12 Month Normalized P/E Ratio - LTM31.8
PER SHARE FIGURES
LT Debt pS28.23
Current Liabilities pS5.79
Tangible Book Value pS - LTM-25.60
Book Value pS - LTM11.58
Capital Invested pS37.48
Cash pS - LTM0.00
Cash Flow pS - LTM9.66
Free Cash Flow pS - LTM9.23
Earnings pS (EPS)5.65
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin31.68
Free Cash Flow Margin 5YEAR AVG32.25
Net Profit Margin0.3
Net Profit Margin - 5YEAR AVRG.0.2
Equity Productivity2.48
Return on Equity (ROE)0.6
Return on Equity (ROE) - 5YEAR AVRG.0.4
Capital Invested Productivity0.58
Return on Capital Invested (ROCI)0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity0.50
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin96.2
Gross Profit Margin - 5YEAR AVRG.1.0
EBITDA Margin - LTM40.6
EBIT Margin - LTM36.5
Pre-Tax Profit Margin0.3
Pre-Tax Profit Margin - 5YEAR AVRG.0.3
Effective Tax Rate1.6
Effective Tax Rate - 5YEAR AVRG.1.4
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee1,726,277
Net Income per Employee457,072
Average Collection Period
Receivables Turnover7.7
Day's Inventory Turnover Ratio
Inventory Turnover1.2
Inventory/Sales3.0
Accounts Payble/Sales2.74
Assets/Revenue2.00
Net Working Capital Turnover3.05
Fixed Assets Turnover0.58
Total Assets Turnover0.5
Revenue per $ Cash3.61
Revenue per $ Plant11.18
Revenue per $ Common Equity2.48
Revenue per $ Capital Invested0.58
Selling, General & Adm/tive (SG&A) as % of Revenue21.3
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue37.1
R&D Expense as % of Revenue - 5YEAR AVRG.37.1

  
Your Recent History
NASDAQ
CELG
Celgene
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:ca D:20190620 16:44:19